1. Home
  2. ZNTL vs TAYD Comparison

ZNTL vs TAYD Comparison

Compare ZNTL & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • TAYD
  • Stock Information
  • Founded
  • ZNTL 2014
  • TAYD 1955
  • Country
  • ZNTL United States
  • TAYD United States
  • Employees
  • ZNTL N/A
  • TAYD N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • TAYD Industrial Machinery/Components
  • Sector
  • ZNTL Health Care
  • TAYD Industrials
  • Exchange
  • ZNTL Nasdaq
  • TAYD Nasdaq
  • Market Cap
  • ZNTL 105.8M
  • TAYD 114.6M
  • IPO Year
  • ZNTL 2020
  • TAYD N/A
  • Fundamental
  • Price
  • ZNTL $1.33
  • TAYD $45.88
  • Analyst Decision
  • ZNTL Buy
  • TAYD
  • Analyst Count
  • ZNTL 7
  • TAYD 0
  • Target Price
  • ZNTL $8.60
  • TAYD N/A
  • AVG Volume (30 Days)
  • ZNTL 1.4M
  • TAYD 32.2K
  • Earning Date
  • ZNTL 08-08-2025
  • TAYD 08-14-2025
  • Dividend Yield
  • ZNTL N/A
  • TAYD N/A
  • EPS Growth
  • ZNTL N/A
  • TAYD 1.48
  • EPS
  • ZNTL N/A
  • TAYD 2.50
  • Revenue
  • ZNTL $26,865,000.00
  • TAYD $42,796,782.00
  • Revenue This Year
  • ZNTL N/A
  • TAYD $15.06
  • Revenue Next Year
  • ZNTL N/A
  • TAYD $8.37
  • P/E Ratio
  • ZNTL N/A
  • TAYD $18.54
  • Revenue Growth
  • ZNTL N/A
  • TAYD N/A
  • 52 Week Low
  • ZNTL $1.01
  • TAYD $29.50
  • 52 Week High
  • ZNTL $5.44
  • TAYD $64.50
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 50.91
  • TAYD 66.36
  • Support Level
  • ZNTL $1.15
  • TAYD $43.92
  • Resistance Level
  • ZNTL $1.38
  • TAYD $45.76
  • Average True Range (ATR)
  • ZNTL 0.10
  • TAYD 2.47
  • MACD
  • ZNTL 0.01
  • TAYD 0.24
  • Stochastic Oscillator
  • ZNTL 75.00
  • TAYD 90.11

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: